The therapy of myeloproliferative diseases:

  • Polycytemia vera
  • Essential trombocytosis
  • Diagnosis of superficial tumors
  • Pain relief of bone metastases

Sodium Orthophosphate (32P) Injection

Sterile solution of sodium orthophosphate in sodium chloride 9 mg/ml solution. The solution is made isotonic by addition of phosphate buffer.

Indications

The therapy of myeloproliferative diseases:

  • Polycytemia vera
  • Essential trombocytosis
  • Diagnosis of superficial tumors
  • Pain relief of bone metastases

Manufacturer

MAP Medical Technologies Oy
Tikkakoski, Finland

Adult

Adult dosage I.V. recommendation: For therapy of polycytemia vera nad trombocytosis 80-110 MBq/m2.

The treatment can be repeated after 12 to 16 weeks with the dosageof 35-75 MBq.

Children

Availability and Deliveries

Daily calibration as requested

Expiracy

3 weeks from the manufactoring date shown in the labels.

Package Sizes

37-370 MBq, 740 MBq/VIAL

Storage

At room temperature (15-25°C).

32

T1/2 = 14.3 d
ß-max = 1.71 MeV

Radioactive Concentration

18.5-185 MBq/ml

Specific Activity

70-750 MBq/mg P

Radiation Dosimetry

Effective dose equivalent (adults): 2.2 mSv/MBq (ref. ICRP 53)

Radiochemical Purity

≥ 98% AS Orthophosphate(32P)

Radionuclidic Purity

≥ 98% 32P (33P ≤ 2%)

Ph

6.0 - 8.0

Order Form

* Required information
** Only if same calibration date

Product *
Required information

Activity *
Required information

Calibration Date (dd.mm.yy) *
Required information

Number of Doses / Pieces * / **
Required information

Special Requirements
Invalid Input

Order Number
Invalid Input

Hospital *
Required information

Contact Person *
Required information

Email *
Invalid Input

Phone *
Required information

Fax
Invalid Input

Notes
Invalid Input

Orders by phone and email

+358 14 334 5212This email address is being protected from spambots. You need JavaScript enabled to view it.